Cell Line : CRO-AP2
Cellosaurus Index : CVCL_1147
Cellosaurus ID : CRO-AP2
CCLE Name
: CROAP2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
GDSC1 Name
, GDSC2 Name
: CRO-AP2
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| CRO-AP2 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | 5-Fluorouracil | GDSC2 | 0.0200 | 20.0000 |
|
| CRO-AP2 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| CRO-AP2 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| CRO-AP2 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| CRO-AP2 | Alisertib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| CRO-AP2 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CRO-AP2 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| CRO-AP2 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| CRO-AP2 | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | AZD4547 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| CRO-AP2 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| CRO-AP2 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| CRO-AP2 | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| CRO-AP2 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZD8055 | GDSC1 | 0.0078 | 2.0000 |
|
| CRO-AP2 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| CRO-AP2 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| CRO-AP2 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| CRO-AP2 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| CRO-AP2 | BI-2536 | GDSC2 | 0.0005 | 0.5000 |
|
| CRO-AP2 | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Bicalutamide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| CRO-AP2 | BMS-345541 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | BMS-754807 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| CRO-AP2 | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CRO-AP2 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| CRO-AP2 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| CRO-AP2 | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| CRO-AP2 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| CRO-AP2 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| CRO-AP2 | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| CRO-AP2 | Crizotinib | GDSC2 | 0.0040 | 8.0000 |
|
| CRO-AP2 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| CRO-AP2 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| CRO-AP2 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| CRO-AP2 | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| CRO-AP2 | Daporinad | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| CRO-AP2 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| CRO-AP2 | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Doxorubicin | GDSC1 | 0.0195 | 5.0000 |
|
| CRO-AP2 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| CRO-AP2 | Entinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Erlotinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| CRO-AP2 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Foretinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| CRO-AP2 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| CRO-AP2 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CRO-AP2 | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| CRO-AP2 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| CRO-AP2 | GSK1904529A | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| CRO-AP2 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CRO-AP2 | I-BET-762 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| CRO-AP2 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| CRO-AP2 | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| CRO-AP2 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| CRO-AP2 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| CRO-AP2 | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| CRO-AP2 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CRO-AP2 | LGK974 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Linsitinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| CRO-AP2 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| CRO-AP2 | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| CRO-AP2 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| CRO-AP2 | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| CRO-AP2 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CRO-AP2 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| CRO-AP2 | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CRO-AP2 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CRO-AP2 | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | OSI-027 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| CRO-AP2 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| CRO-AP2 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| CRO-AP2 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| CRO-AP2 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| CRO-AP2 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| CRO-AP2 | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CRO-AP2 | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| CRO-AP2 | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| CRO-AP2 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Pictilisib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| CRO-AP2 | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| CRO-AP2 | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| CRO-AP2 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| CRO-AP2 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | Rapamycin | GDSC2 | 0.0001 | 0.1000 |
|
| CRO-AP2 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| CRO-AP2 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| CRO-AP2 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | Ruxolitinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | Saracatinib | GDSC1 | 0.0078 | 2.0000 |
|
| CRO-AP2 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | SB505124 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Sepantronium bromide | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| CRO-AP2 | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| CRO-AP2 | Sorafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| CRO-AP2 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| CRO-AP2 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| CRO-AP2 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| CRO-AP2 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | TW 37 | GDSC1 | 0.0195 | 5.0000 |
|
| CRO-AP2 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | UNC0638 | GDSC1 | 0.0781 | 20.0000 |
|
| CRO-AP2 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| CRO-AP2 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| CRO-AP2 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| CRO-AP2 | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| CRO-AP2 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| CRO-AP2 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| CRO-AP2 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| CRO-AP2 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| CRO-AP2 | YK-4-279 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| CRO-AP2 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| CRO-AP2 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC